Gene: IFT43
Official Full Name: intraflagellar transport 43provided by HGNC
Gene Summary: This gene encodes a subunit of the intraflagellar transport complex A (IFT-A). IFT-A is a multiprotein complex that plays an important role in cilia assembly and maintenance by mediating retrograde ciliary transport. Mutations in this gene are a cause of cranioectodermal dysplasia-3 (CED3), also known as Sensenbrenner syndrome. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Dec 2011]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO30914 | IFT43 Knockout cell line (HeLa) | Human | IFT43 | 1:3~1:6 | Negative | Online Inquiry |
KO30915 | IFT43 Knockout cell line (HCT 116) | Human | IFT43 | 1:2~1:4 | Negative | Online Inquiry |
KO30916 | IFT43 Knockout cell line (HEK293) | Human | IFT43 | 1:3~1:6 | Negative | Online Inquiry |
KO30917 | IFT43 Knockout cell line (A549) | Human | IFT43 | 1:3~1:4 | Negative | Online Inquiry |
IFT43 Gene Knockout Cell Lines are genetically modified cell lines specifically engineered to exhibit the absence of the IFT43 gene, a key component involved in intraflagellar transport. This gene plays a critical role in the formation and maintenance of cilia and flagella, vital structures for cellular signaling and motility. By employing CRISPR-Cas9 technology, these knockout cell lines enable researchers to elucidate the specific functions of IFT43 in cellular processes, including its influence on ciliary dynamics and signaling pathways.
The core functionality of IFT43 Gene Knockout Cell Lines lies in their ability to facilitate the study of cilia-related disorders, such as ciliopathies and other diseases linked to impaired ciliary function. By comparing these knockout cell lines to wild-type counterparts, researchers can investigate the downstream effects of IFT43 deficiency, enabling a deeper understanding of the molecular mechanisms underlying various pathologies. This makes the cell lines valuable not only for basic research but also for the development of potential therapeutic strategies.
Unique advantages of IFT43 Gene Knockout Cell Lines include their high specificity and reproducibility in experimental conditions. Unlike other gene editing methods that may introduce off-target mutations, our CRISPR-derived lines are meticulously validated for accurate targeting of the IFT43 locus. Furthermore, they are provided with detailed characterization data, ensuring reliability in experimental outcomes.
For researchers and clinicians, the ability to study the precise role of IFT43 in disease mechanisms can lead to groundbreaking insights and novel therapeutic avenues. These knockout cell lines represent a powerful toolset for advancing the understanding of ciliary biology, providing significant value in both academic and clinical settings.
Our company prides itself on a commitment to excellence in providing high-quality genetic tools and reagents for biological research. With a strong emphasis on innovation and scientific rigor, we strive to support the research community in its endeavors to unravel the complexities of cellular biology and disease.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.